Advocacy intelligence hub — real-time data for patient organizations
Kineret: FDA approved
Treatment of neonatal-onset multisystem inflammatory disease (NOMID)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Kineret
(anakinra)Orphan drugSwedish Orphan Biovitrum AB (publ)
Interleukin-1 Receptor Antagonist [EPC]
12.1 Mechanism of Action KINERET blocks the biologic activity of IL-1 alpha and beta by competitively inhibiting IL-1 binding to the interleukin-1 typ...